Enhancing the Use of GLP-1 RAs in Patients With Type 2 Diabetes to Improve Individualized Patient-Centered Care (Nov 01, 2022 - Oct 31, 2023)

Enhancing the Use of GLP-1 RAs in Patients With Type 2 Diabetes to Improve Individualized Patient-Centered Care is organized by ProCE, LLC.,,Release : November 01, 2022 ,Expires : October 31, 2023,,Description:,Expert faculty provide insights on the benefits of GLP-1 receptor agonists for the treatment of type 2 diabetes.,,Learning Objectives:,• Identify the physiologic actions of GLP-1 RAs that contribute to metabolic, renal, and cardiovascular benefits in patients with type 2 diabetes,• Compare the available GLP-1 RAs with regard to their dosing, administration, glycemic effects, and extraglycemic benefits,• Develop treatment plans that incorporate GLP-1 RAs early in the management of diabetes based on guideline recommendations, clinical evidence, and individualized patient needs and preferences,• Devise strategies to improve patient acceptance, tolerance, and adherence to GLP-1 RA treatment